Metabolic indicators track glaucoma risk without establishing causation
A single peer-reviewed study linked blood-based metabolic indicators with later glaucoma diagnoses in UK Biobank participants. Measures incorporating waist size showed stronger associations than the triglyceride-glucose index alone. A genetic analysis offered limited additional support, with sensitivity tests remaining inconclusive. Observational diagnoses and possible detection bias limit interpretation; the indicators are neither standalone eye tests nor proof that changing metabolism prevents glaucoma.
Science··Evening
Metabolic measures alongside later eye diagnoses
A single peer-reviewed observational study followed 396,213 participants of European ancestry in UK Biobank, a British health research database. None had glaucoma at baseline. Over a mean 8.06 years, 6,957 new diagnoses were identified. The researchers examined the triglyceride-glucose index, or TyG, which combines blood lipid and glucose measurements, alongside versions incorporating body size and proportions. The design compared existing measurements and later diagnoses rather than assigning people a treatment.[1]
Waist measurements carry a stronger association
After statistical adjustment, the hazard ratio was 1.05 for each standard-deviation increase in TyG. With waist circumference incorporated into the index, that estimate reached 1.30. These are standardized associations for different indicators, not estimates of a treatment benefit. For TyG alone, risk estimates followed a curve, with increases at the low and high extremes rather than a straight upward trend. Accounting for diabetes weakened that association, while effects relating the measures to intraocular pressure were small.[1]
Genetic analysis leaves the causal question open
An accompanying Mendelian randomization analysis, which uses genetic variants as statistical instruments, gave a suggestive main estimate. Its sensitivity methods were not statistically significant and the instruments were heterogeneous, leaving causation uncertain. Glaucoma diagnoses came from self-reports, procedures and hospital codes, without standardized examinations for every participant. More frequent healthcare contact among people with metabolic disorders could affect detection. The indicators require external validation and cannot replace eye examinations or show that changing metabolic status prevents glaucoma.[1]
